This product is available in both preservative-free and preserved formulations, each supplied in a 30 mL vial at a concentration of 500 mg/mL
The primary objective was to determine whether dapagliflozin 10 mg reduces the incidence of the composite endpoint of 50% sustained decline in eGFR, progression to end-stage kidney disease (ESKD) (defined as sustained eGFR 40% and evidence of structural heart disease to determine whether dapagliflozin reduces the risk of cardiovascular death, hospitalization for heart failure or urgent heart failure visits
I bde Storgteborg och Stormalm och i de centrala delarna av Gteborg och Malm kade priserna med runt +1%
Several scenarios warrant medical consultation before, during, or after stopping treatment
Moreover, as new indications are approved, avoiding unintentional duplicate therapy is essential
Ethics declarations Competing interests L.A.L